Diagnostics; making a difference

Member Press Releases

Current Articles | Categories | Search | Syndication

29 June 2015  Joanne Hunter
BBI Group develops rapid test to aid identification and potentially help minimise spread of Ebola virus
By Joanne Hunter @ 16:05 :: 21 Views

29th June 2015 – CARDIFF, U.K. – The BBI Group (BBI) today announced it has developed in collaboration with the Defence Science and Technology Laboratory (Dstl) and licensed, through technology transfer company Ploughshare Innovations, a rapid test for Ebola. The assay, which is in the process of being verified to allow EUA submission, will be used to test patients suspected of Ebola infection to screen and potentially help with how they are subsequently managed. The test, utilising lateral flow technology, can provide a result in approximately 20 minutes.

Read More

24 June 2015  Joanne Hunter
Publication of Annual Report
By Joanne Hunter @ 11:47 :: 40 Views

The Company announces that its Annual Report and Accounts for the year ended 31 December 2014, together with a notice of the Annual General Meeting and accompanying form of proxy, are available to view on the Company’s website at www.proteomics.com, and will be posted to
shareholders imminently.

Read More

24 June 2015  Joanne Hunter
Placing to raise £2.5 million
By Joanne Hunter @ 10:45 :: 53 Views

23 June 2015: Proteome Sciences plc (AIM:PRM) ("Proteome Sciences" or the "Company") is pleased to announce it has conditionally raised approximately £2.5 million, before expenses, through the placing of 13,861,112 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares" and the "Placing Shares") at a price of 18 pence per Ordinary Share (the "Placing Price" and the "Placing").

Read More

23 June 2015  Joanne Hunter
Control the Quality of Your Flow
By Joanne Hunter @ 12:20 :: 41 Views

Commercially available Quality Control materials bring third party verification to analytical and diagnostic procedures. This is an increasingly important requirement for laboratories working towards or maintaining ISO 15189 accreditation. Flow cytometry systems, such as those from BD Biosciences and Beckman Coulter®, are well supported with a wide range of speciality control materials from Streck, supplied in the UK by Alpha Laboratories.

Read More

23 June 2015  Joanne Hunter
Optimised Fluorescence for Rapid Sepsis Species Identification Assays
By Joanne Hunter @ 12:07 :: 37 Views

QuickFISH™ is a rapid, molecular diagnostic platform, developed by AdvanDx, and now exclusively available in the UK from Alpha Laboratories. It provides 20 minute species identification of bacteria, directly from positive blood cultures. This enables clinicians to prescribe the correct antimicrobial therapy for patients with bloodstream infections much earlier, ensuring better patient outcome, reduced hospital stays and lower medical costs.

Read More

16 June 2015  Joanne Hunter
Beckman Coulter Diagnostics Showcases the New DxN VERIS Molecular Diagnostics System at the 2015 EuroMedLab
By Joanne Hunter @ 15:29 :: 97 Views

Nyon, Switzerland — (16 June 2015) Beckman Coulter Diagnostics is showcasing its revolutionary DxN VERIS Molecular Diagnostics System* at Innovations to Improve Workflow for the Diagnostics Laboratory, booth D23 and D24 at the IFCC-EFLM EuroMedLab, 22-24 June 2015, Palais des Congrès, Paris, France.

Read More

01 June 2015  Joanne Hunter
Supplying Quality to Science Since 1975 Celebrating 40 Years
By Joanne Hunter @ 11:20 :: 84 Views

In June 2015 Alpha Laboratories celebrates 40 years of providing support to UK and international scientists. The company remains today, as always, a family run business with the same vision and ethos, whilst continuing to focus on customer needs and ever changing technologies.

Read More

01 June 2015  Joanne Hunter
Preliminary results for the year ended 31st December, 2014
By Joanne Hunter @ 08:18 :: 84 Views

29th May,

29th May, 2014


  • Revenue increase 9% to £1.56m (2013:£1.43m) excluding equipment on loan £nil (2013: £0.71m)
  • Licenses/Sales/Services revenue up 7% to £1.30m (2013:£1.21m) excluding equipment on loan
  • TMT® sales rose 31% in 2014
  • Loss after tax £3.57m (2013:£3.15m)
  • Cash at year-end £1.87m (2013:£0.60m)
  • Strong underlying growth in biomarker services
  • $2m services contract from Genting TauRx – co- owners of companion diagnostic
  • Excellent safety characteristics in toxicity screens for CK1d compounds
  • First MCI/AD panel in blood – for clinical tests, stratification, drug development
  • HUPO Science and Technology Award for TMT®



Read More

01 June 2015  Joanne Hunter
EKF Diagnostics highlighting cancer molecular diagnostics products at ASCO 2015
By Joanne Hunter @ 08:12 :: 85 Views

Cardiff, UK – 27 May 2015 – EKF Diagnostics will be exhibiting its range of molecular diagnostics products supporting personalized medicine in cancer at the 2015 American Society of Clinical Oncology (ASCO) annual meeting, 29th May to 2nd June, McCormick Place, Chicago, Illinois. Here 30,000 oncology professionals from around the world will be brought together to discuss the very latest in treatment modalities, therapies and research in the field, in order to apply this knowledge to enhance cancer patient care.

Read More

01 June 2015  Joanne Hunter
Novel in-line blood gas analyser demonstrated in Germany at H.I.T. 2015
By Joanne Hunter @ 08:08 :: 86 Views

Cambridge, UK – 27 May 2015 Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will be exhibiting its new Proxima patient dedicated arterial blood gas analyser for the first time in Germany at H.I.T. 2015. The ‘Hamburger Intensivtage’, 29-30th May, will focus on the effective diagnosis and treatment of critically ill patients in alignment with the very latest research.

Read More

Previous Page | Next Page